38 results
424B3
SHPH
Shuttle Pharmaceuticals Holdings Inc
22 Mar 24
Prospectus supplement
6:07am
is the development of a clinical plan with aggressive timelines and support within the radiation oncology community to participate in clinical trials … and the medical community; and
a continued acceptable quality profile of our product candidates following approval.
Many of the above-listed risk factors
8-K
EX-99.1
SHPH
Shuttle Pharmaceuticals Holdings Inc
11 Dec 23
Shuttle Pharmaceuticals Submits IND Application to the U.S. FDA for Ropidoxuridine Phase II Clinical Trial for Patients with Glioblastoma
9:00am
Pharma team, as well as support from the broader cancer community, including the National Institutes of Health’s National Cancer Institute and Small
424B3
SHPH
Shuttle Pharmaceuticals Holdings Inc
24 Aug 23
Prospectus supplement
2:00pm
formulation of IPdR/TPI, is the development of a clinical plan with aggressive timelines and support within the radiation oncology community to participate … by the medical community and any new treatments that enter the market. We believe that a significant number of products are currently under development, and may
DEF 14C
SHPH
Shuttle Pharmaceuticals Holdings Inc
16 Jun 23
Information statement
6:30am
to applicable community property laws.
In computing the number and percentage of shares beneficially owned by a person as of a particular date, shares
PRE 14C
kpc3qdb
5 Jun 23
Preliminary information
4:29pm
DEF 14A
fdhw 3qyy6bpdhet9urk
21 Nov 22
Definitive proxy
5:28pm
8-K
EX-99.1
kwe zodwp30jb6
1 Nov 22
Shuttle Pharmaceuticals Appoints Bette Jacobs to its Board of Directors
9:00am
8-K
EX-3.1
6xmrzh i4z22y1n6b1x
1 Nov 22
Shuttle Pharmaceuticals Appoints Bette Jacobs to its Board of Directors
9:00am
DRS
y6c0fg i2pdz5fmwo0l
29 Sep 22
Draft registration statement
12:00am
424B4
xpcndezd qj
31 Aug 22
Prospectus supplement with pricing info
6:16am
S-1/A
ds7g7jdz r5i8
23 Jun 22
IPO registration (amended)
5:24pm
S-1/A
EX-10.9
f2geogg
23 Jun 22
IPO registration (amended)
5:24pm
S-1/A
EX-10.12
wvft6 lrx
23 Jun 22
IPO registration (amended)
5:24pm
S-1/A
EX-10.7
5hjfm459otmxysdgtx
23 Jun 22
IPO registration (amended)
5:24pm
S-1/A
EX-10.4
v6bka15bmu1r5kzx7
23 Jun 22
IPO registration (amended)
5:24pm